InvestmentPitch Media Video Discusses FSD Pharma’s Continued Development of its Exciting New Rapid Detox Drink UNBUZZD™, with Video Comments from Kevin Harrington
- Kevin Harrington endorses UNBUZZD™
- Global hangover cure products market projected to reach US $6.2 billion by 2030
- Interim results for Lucid-MS Phase I trial show well tolerance
- None.
VANCOUVER, British Columbia, Sept. 22, 2023 (GLOBE NEWSWIRE) -- FSD Pharma Inc. (NASDAQ:HUGE) (CSE:HUGE) (FSE:0K9A), a biotechnology company building a portfolio of innovative assets and biotech solutions for the treatment of challenging neurodegenerative, inflammatory and metabolic disorders, continues with the development of its exciting new rapid detox drink UNBUZZD™.
Today, we’re following up on our August 2nd feature video in which we discussed UNBUZZD™, a proprietary formulation of natural ingredients, vitamins, and minerals to help relieve the effects of alcohol consumption, such as inebriation, and restoring normal lifestyle.
A Media Snippet accompanying this announcement is available by clicking on the image or link below:
For more information, please view the InvestmentPitch Media video which provides additional information about this news and the company, including a short video by Kevin Harrington of Shark Tank fame. If you are unable to view this video, please watch on InvestmentPitch Media’s YouTube channel at this link: (click here)
In that video, Kevin Harrington, an original “shark” on the TV hit show Shark Tank and the creator of the infomercial, introduced UNBUZZD™ and his involvement with the rapid detox drink.
Kevin has joined us again today to update us on the product and the impressive team he put together that has cumulatively generated billions of dollars of sales and value for brands and shareholders. Be sure to stay to the end of this short video, which Kevin sums up by giving the product his “whole-hearted endorsement”.
Following a product testing, John Duffy placed the following post on Facebook. “I had the pleasure of visiting our partners at the FSD Pharma (Nasdaq:HUGE) HQ in Toronto, Canada last week. On day one of my visit, I tried out samples of UNBUZZD and it is simply amazing!!! It was a tough workday, I had to get my Blood Alcohol Content (BAC) up to just under .08 (validated by a breathalyzer). I then tried UNBUZZD, within 30 minutes I started to become much more alert and focused. By the time I passed 70 minutes my BAC had dropped from just under .08 to just over .05. Later that day I participated in regular meetings and the dinner with board members and investors. I have worked in the food and beverage industry since I was in college. UNBUZZD is one of the most innovative and disruptive new products that I have seen during my career.”
According to Grandview Research, the global hangover cure products market size was estimated at US
The company also recently reported that interim results for the first-in-human single ascending dose Phase I clinical trial for its novel drug candidate Lucid-21-302 (“Lucid-MS”), an orally-administered treatment for Multiple Sclerosis, showed the compound was well tolerated for the first 4 cohorts, with an addendum report describing the results of the fifth cohort due by the end of the month. In 2022, the Global MS treatment market was estimated at US
The shares are trading at US
About InvestmentPitch Media
InvestmentPitch Media leverages the power of video, which together with its extensive distribution, positions a company’s story ahead of the 1,000's of companies seeking awareness and funding from the financial community. The company specializes in producing short videos based on significant news releases, research reports and other content of interest to investors.
Disclaimer
The information in this Investmentpitch Media Ltd video is for the viewers information only. FSD Pharma has paid a fee not exceeding
CONTACT:
InvestmentPitch Media
Barry Morgan, CFO
bmorgan@investmentpitch.com
